Linnea SA Receives Swiss Narcotics License allowing for the Production and Exportation of High THC Active Pharmaceutical Ingredients
January 16, 2023 05:00 ET
|
Linnea
RIAZZINO, Switzerland, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Linnea SA (“Linnea,” or “the Company”), a leading pharmaceutical manufacturer with over 40 years of experience, has been granted a narcotics...
Volunteer Botanicals’ Satival Cannabinoid Powders Demonstrate Potential in Clinical Study
January 10, 2023 16:35 ET
|
Volunteer Botanicals
MURFREESBORO, Tenn., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Volunteer Botanicals, which develops consistent, versatile hemp-based cannabinoid ingredients for use in a wide variety of consumer products,...
InMed Provides Business Update and Milestones for 2023
January 10, 2023 07:30 ET
|
InMed Pharmaceuticals Inc.
Complete Phase 2 clinical trial enrollment in Epidermolysis Bullosa in 1Q 2023Progress preclinical research in glaucoma in preparation for human trialsAdvance research using rare cannabinoids in...
GPOPlus+ Assigned Exclusive Trademark License Agreement for the Creation of Yuengling’s Ice Cream Flavored CBD + Cannabinoid Products
December 12, 2022 09:15 ET
|
GPO PLUS INC.
Las Vegas, NV and Atlanta, GA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- GPO Plus, Inc. (OTCQB: GPOX), a brand creation and distribution company focused on independent and regional retailers with an ever...
Dyadic Reports Third Quarter 2022 Financial Results and Highlights Recent Company Developments
November 10, 2022 16:00 ET
|
Dyadic International, Inc.
Received regulatory approval from South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 clinical trial to demonstrate clinical safety and antibody response in humans for...
KND Labs Earns NSF Certification
October 10, 2022 12:30 ET
|
KND Labs
DENVER, Oct. 10, 2022 (GLOBE NEWSWIRE) -- KND Labs has been granted NSF certification, the company announced today. The NSF certification further commits KND Labs as the most compliant CBD...
SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility
September 26, 2022 05:00 ET
|
SOMAÍ Pharmaceuticals
LISBON, Portugal, Sept. 26, 2022 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new state-of-the-art pharmaceutical EU-GMP facility in Portugal. SOMAÍ’s phase 1...
BioLife Sciences Inc. Expands Product Offerings in the Orthomolecular Medicine and Natural Health Markets with a Focus on Hemp Products
August 24, 2022 08:00 ET
|
BioLife Sciences Inc.
HENDERSON, Nev., Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (“BioLife” or the “Company”) (OTC: BLFE) announced today that it will be expanding the scope of its orthomolecular medicine...
BioLife Sciences Announces Launch of Hemp-Based Product Line
August 17, 2022 08:00 ET
|
BioLife Sciences Inc.
HENDERSON, Nev., Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (“BioLife” or the “Company”) (OTC: BLFE) announced today the launch of its first line of cannabinoid consumer products. The...
357 Hemp Logistics' Kevin Schultz to Present “How to Avoid Costly Mistakes Transporting Hemp” at Southern Hemp Expo; Appointed to Hemp Alliance of Tennessee Board
August 16, 2022 15:05 ET
|
The 357 Company
357 Hemp boosts complimentary hemp cargo insurance coverage from $50,000 per shipment to $75,000357 Hemp Logistics adds international shipping and expands capacity to serve the growing industrial hemp...